Tag: Pharmaceuticals

Transforming Weight Management: The Rise of Oral GLP-1 Medications

Discover how oral GLP-1 medications like Wegovy and Foundayo are transforming healthcare and improving accessibility to weight management solutions.

Minnesota Legislation to Support Hospitals in 340-B Prescription Drug Program

Minnesota's Senate approves a bill to support 340-B hospitals in acquiring discounted medications. Learn about its impact and legislative challenges ahead.

Proposed $35 Insulin Cap Under Private Insurance Highlights Financial Burdens

Explore proposed legislation aiming to cap insulin costs at $35, addressing financial burdens on families managing diabetes. Current healthcare challenges assessed.

Insurance Challenges with GLP-1 Coverage for Weight Loss

Explore the challenges in insurance coverage for GLP-1 weight-loss medications as demand rises and insurers tighten restrictions.

Medicare Part B Payment Adjustments Impacted by Noncovered Drugs

Explore how Medicare Part B payment adjustments for self-administered medications impact beneficiaries and the healthcare market.

Regulatory Changes Impacting Healthcare Insurance and Claims Processing

Explore new healthcare regulations affecting insurance claims. Understand the impact of major legal shifts and the evolving healthcare landscape for professionals.

Improving Medication Adherence through Medicare Changes

Discover how recent Medicare changes are improving medication adherence and access for seniors, particularly those with cardiovascular conditions.

CorMedix Expands Drug Pipeline and Reimbursement Strategies at Citizens Life Sciences Conference

Discover how CorMedix is expanding its drug pipeline and adapting strategies for reimbursement in the evolving healthcare landscape.

Medicare Drug Price Negotiation Insights and Implications

Explore the implications of Medicare's Drug Price Negotiation Program, its impact on costs, and the ongoing negotiations for 2028. Discover key details.

Trump Administration Proposes MFN Deals in Pharmacy Sector

Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.